Skip to main content
. 2016 Jun 23;9:3763–3770. doi: 10.2147/OTT.S102909

Figure 2.

Figure 2

Kaplan–Meier estimates of overall survival.

Notes: Panel shows the results of the analysis of efficacy of immunotherapy compared with control (median survival in immunotherapy, 29.70 months; in control, 19.90 months; P=0.036).